Enhancement of transdermal penetration and bioavailability of poorly soluble acyclovir using solid lipid nanoparticles incorporated in gel cream

Indian Journal of Pharmaceutical Sciences

Volumn 75, Issue 2, 2013, Pages 138-142

  Gide, P S ^a   Gidwani, S K ^a   Kothule, K U ^a  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Acyclovir; homogenisation; medium chain triglyceride; solid lipid nanoparticles

Indexed keywords

ACICLOVIR; DRUG CARRIER; MEDIUM CHAIN TRIACYLGLYCEROL; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CHEMICAL PROCEDURES; CREAM; DERMIS; DIFFUSION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; EPIDERMIS; EX VIVO STUDY; GEL; HERPES SIMPLEX; HIGH PRESSURE HOMOGENIZATION; IN VITRO STUDY; NONHUMAN; RAT; STEADY STATE; ZETA POTENTIAL;

EID: 84881562909     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parry GE, Dunn P, Shah VP, Pershing LK. Acyclovir bioavailability in human skin. J Invest Dermatol 1992;98:856-63
2. Zanowiak P, Jacobs MR. In: Laitin SC, editor. Handbook of Nonprescription Drugs. Washington, DC: American Pharmaceutical Association; 1982. p. 523-9
3. Williams A. Transdermal and Topical Drug Delivery. 1st ed. London: Pharmaceutical Press; 2003
4. El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol 2001;53:1311-22
5. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14
6. Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002;54:S41-55
7. Volpato NM, Santi P, Colombo P. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharm Res 1995;12:1623-7
8. Volpato NM, Nicoli S, Laureri C, Colombo P, Santi P. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release 1998;50:291-6
9. Spruance SL, Crumpacker CS. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit. Am J Med 1982;73:315-9
10. Cooper ER, Merritt EW, Smith RL. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J Pharm Sci 1985;74:688-9
11. Berthold A, Cremer K, Kreuter J. Collagen microparticles: Carriers for glucocorticosteroids. Eur J Pharm Biopharm 1998;45:23-9
12. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. Podophyllotoxin- loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110:296-306
13. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, et al. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-95
14. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191-5
15. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189-96
16. Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers: Characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493-502
17. Smith RL, Morroni J, Wilcox CL. Lack of effect of treatment with penciclovir or acyclovir on the establishment of latent HSV-1 in primary sensory neurons in culture. Antiviral Res 2001;52:19-24
18. Friedman D, Carmei Y, Schwartz J, Haim A. Topical and transdermal delivery system utilizing submicron oil spheres. United States Patent (US 6,113,921
19. Dubey V, Mishra D, Asthana A, Jain NK. Transdermal delivery of a pineal hormone: Melatonin via elastic liposomes. Biomaterials 2006;27:3491-6
20. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis 2009;8:6
21. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189-96
22. Maia CS, Mehnert W, Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000;196:165-7
23. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675-711
24. Wissing SA, Müller RH. Solid lipid nanoparticles (SLN) -A novel carrier for UV blockers. Pharmazie 2001;56:783-6